Jan 14 (Reuters) - The U.S. Food and Drug Administration approved Pfizer Inc's drug Cibinqo to treat eczema, a skin disease, the company said on Friday. (Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
Stock Market News in real time
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
28.16 USD | +1.26% | +9.83% | 159B | ||
- Stock Market
- Stock Market News in real time
- Economy
- U.S. FDA approves Pfizer's drug to treat eczema